Fenbendazole for Dogs

Fenbendazole is a deworming drug used in many animals that is now under investigation as an anti-cancer drug.

Key Takeaways

  • Fenbendazole treats parasitic worms in dogs. It may have potential as a cancer treatment as well.
  • Side effects of fenbendazole are vomiting and diarrhea, which are quite rare when given short-term to treat parasitic infections.
  • You do not need a prescription for fenbendazole for dogs but should always discuss starting any new medication with your veterinarian.
  • Fenbendazole may cause liver damage in dogs when given long-term, as this has happened in a human.
  • Ivermectin and fenbendazole are not the same medication and work differently.

What Is Fenbendazole for Dogs?

Fenbendazole is a deworming/antiparasitic drug commonly given to dogs and other animals. It is part of a class of drugs called benzimidazoles.

It can be given as a pill, liquid, paste, or powder. The treatment duration can vary depending on what type of parasite is being treated.

Fenbendazole is not well absorbed in the intestine, with reports ranging from 10-50% absorption. This may be because it is not very soluble (easily dissolved) in water.

Brand Names

Panacur®

Safe-Guard®

How Fenbendazole for Dogs Works

Fenbendazole acts by disrupting tubulin. Tubulin is a protein essential to produce cellular structures called microtubules.

This is relevant to cancer therapy because microtubules are required for cell division and replication. The microtubules must assemble and disassemble into flexible lines for a cell to make a copy of itself – which cancer cells do a lot of!

In fact, many of our anti-cancer drugs, like vinculin, vincristine, Taxol, and paclitaxel, all work by disrupting the process of breaking down and rebuilding microtubules.1,2

This tubulin disruption is why fenbendazole has caught some researchers’ interest as a possible repurposed drug for cancer treatment.

Could it be an over-the-counter chemotherapy drug if used over the long term?

How researchers came to this question is an interesting story, and helps explain some of the online fuss around fenbendazole, so let’s talk about the fenbendazole’s origin story.

The Story of How a Dewormer Seemed to Stop Lymphoma

Remember that fenbendazole was initially developed to kill parasites, not treat cancer. The microtubules of parasitic worms are very different from higher mammals like dogs, so it was not previously expected that fenbendazole would affect mammalian microtubules similarly.

However, one lab stumbled on the possibility that fenbendazole might have anti-tumor effects in mice. This lab was studying lymphoma by injecting human lymphoma cells into mice.2

Why Didn’t the Mice Get Lymphoma?

This is a well-established way to create cancer in lab mice, so the researchers were surprised when their injections failed to produce tumors. Why weren’t these lab mice getting lymphoma, as they normally would?

The only difference the researchers could identify was that the mice were fed a diet with fenbendazole added due to an outbreak of pinworm (an intestinal parasite) in the facility.

Was It the Fenbendazole?

The fenbendazole-laden diet was originally designed to be autoclaved, or sterilized with high heat. Because high heat processing is known to degrade the nutritional value of food, extra vitamins were supposed to be added to the food to compensate.

But this facility did not have the equipment to autoclave the food, so that step was skipped. They didn’t skip the extra vitamins, however. So the diet fed to the mice in this trial was filled with fenbendazole and a high dose of vitamins.

Perhaps that was the reason lymphoma wasn’t taking hold of these mice?

Feeding Trials Repeated

The lab decided to determine if the vitamins, the fenbendazole, or both together caused their tumor model to fail.

They repeated the experiment and fed four groups of mice four different ways:

  • one fed standard feed (no fenbendazole or vitamins added) was the control group
  • one fed standard feed plus vitamin supplements
  • one fed standard feed plus fenbendazole
  • one fed standard feed plus both vitamins and fenbendazole

Fendbendazole Plus Vitamins

This time, the tumor cell injections worked in all the treatment groups, and the mice got lymphoma, so their experiment was not duplicated. However, the researchers still made some interesting observations.

Tumor growth in the control group, the vitamins alone group, and the fenbendazole alone groups was similar. (Fenbendazole tended to increase tumor growth but not statistically significantly.)

Tumor growth also occurred in the group of mice fed both fenbendazole and extra vitamins. However, there was a long delay before tumor growth began.

These mice also had a higher level of neutrophils (a type of immune cell). The researchers concluded that fenbendazole with high-dose vitamins may have inhibited tumor growth and proposed that other researchers consider this in their future tumor studies.

Research Is Ongoing

Since that study was completed in 2008, interest has arisen in fenbendazole’s effects on cancer because researchers want to avoid complications in future mouse studies and as a potential therapeutic in humans and other animals.

In Vitro Studies

Remember that oral fenbendazole only has a 10-50% absorption rate, so it is important for researchers to learn how to make it more bioavailable.

A few studies in cells grown in culture dishes have yielded some interesting findings and have begun to address how to deliver the poorly absorbed drug to cancer cells. Some of these studies have included cell lines with leukemia, prostate cancer, and canine melanoma.3-5

In Vivo Studies

There was also a study in mice using a breast cancer model (not in combination with vitamins), which found no effect on tumors in the mice alone or when combined with radiation. However, the study did see an effect on cells cultured in dishes.1

This is a good example of why scientific research can feel frustrating. Many therapies that show promise in petri dishes fail to perform in living bodies. And sometimes what performs in petri dishes and mice doesn’t perform in dogs or humans.

The long and slow process can reveal really promising therapies over time, however.

What We Are Still Learning About Fenbendazole and Cancer

Overall, the study of fenbendazole as an anti-cancer agent is in its very early stages, and several aspects must be addressed, including:

  • Dosing
  • Safety
  • Improving delivery to cancer cells
  • What cancers it might be effective in
  • What therapies might it best be paired with

Be Skeptical of Incredible Claims

Internet claims suggest this drug can and should be used to treat every cancer, which is usually a good cause for alarm. Fenbendazole has certainly been a victim of this sort of unearned hype.

After a human lung cancer patient claimed to be cured by fenbendazole and a bit of social media fervor in South Korea, the belief that this drug could cure non-small cell lung cancer took off (and led to at least one case of liver toxicity).6,7

A high-profile singer and comedian in South Korea amplified the fenbendazole message when he was diagnosed with lung cancer and started taking the drug. Eight months later, he denounced his earlier message, said he had seen no benefit and suffered from severe side effects. He later died of his disease.6

Fenbendazole Shows Promise, But Has Not Been Thoroughly Tested In Any Cancer

Researchers are still in the early stages of testing fenbendazole as a cancer treatment. It has not been tested for efficacy in any cancer yet. The original tumor model that it affected was lymphoma, and hopefully, research in that direction will be productive.

But today, this should be considered a promising potential therapy awaiting more testing. Using fenbendazole to treat cancer in dogs or humans is based more on theory and hope than research.

Common Uses of Fenbendazole for Dogs

Fenbendazole is used routinely for short time periods (a few days only) to treat parasitic worms in dogs and other animals.

It is not routinely used for longer than a few days, and the risk of liver and other organ toxicity is a concern.

When to Not Use Fenbendazole

There are no known drug interactions with fenbendazole. However, it is mostly used in short courses of therapy, so we don’t yet know if there may be drug interactions that develop when it is used long-term (such as it certainly would be for cancer treatment).

There was one known case of liver damage caused to a human patient taking fenbendazole in combination with her chemotherapeutic drugs without consulting her physician.

As the drug is processed in the liver, it is possible that long-term use with other drugs that stress the liver could be harmful.

Fenbendazole Dosage for Dogs

This drug is usually given based on body weight when used as a dewormer. For example, Panacur recommends 50 mg/kg (22.7 mg/lb) daily.

Fenbendazole may come as a liquid, powder, or paste and is typically mixed with food. Treatment duration is based on what type of parasite is being treated.

Always follow your veterinarian’s specific doses and schedule for your dog’s case.

What If I Miss a Dose?

This is a once-daily medication, so if you miss a dose and it is the same day, give the dosage when you remember. Then alter the dosage timing of the following doses to 24 hours from when you gave the last dosage.

If it has been more than a day without fenbendazole, skip the missed dose and call your veterinarian to find out if you need to extend the course of treatment. Do not give a double dose of fenbendazole to “make up” for a missed dose, as this might harm your dog.

Storage and Handling

Fenbendazole can be stored at room temperature (68-77 °F).

Safety and Side Effects

This is a well-tolerated drug when given over the typical time course, with the most common side effects being vomiting or diarrhea. These side effects are still rare, usually affecting about 1% of dogs.

Some animals may hypersalivate after an oral dose. This resolves on its own without any medication or treatment.

We don’t yet know what side effects may occur when fenbendazole is given long-term, so more interactions may show up as cancer studies continue.

Our Take on Fenbendazole for Dog Cancer

Although there is some promising research, there is not enough evidence to recommend fenbendazole for cancer treatment.

We do not know enough about the long-term effects in dogs or interactions with chemotherapies. This is important to consider because, remember, fenbendazole’s mechanism of action is similar to many chemotherapeutic drugs already in use as first-line treatments in cancer.

Fenbendazole may offer another line of treatment in the future. Still, if you want to consider using this drug to treat your dog’s cancer, it is essential to discuss it with your veterinarian first.

At this point we don’t understand how effective or safe it is as a chemotherapeutic.

  1. Duan Q, Liu Y, Booth CJ, Rockwell S. Use of fenbendazole-containing therapeutic diets for mice in experimental cancer therapy studies. J Am Assoc Lab Anim Sci. Mar 2012;51(2):224-30.
  2. Gao P, Dang CV, Watson J. Unexpected antitumorigenic effect of fenbendazole when combined with supplementary vitamins. Journal of the American Association for Laboratory Animal Science. 2008;47(6):37-40.
  3. Kim S, Perera SK, Choi SI, Rebhun RB, Seo KW. G2/M arrest and mitotic slippage induced by fenbendazole in canine melanoma cells. Vet Med Sci. May 2022;8(3):966-981. doi:10.1002/vms3.733
  4. Koohi Moftakhari Esfahani M, Alavi SE, Cabot PJ, Islam N, Izake EL. β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells. Pharmaceutics. Apr 18 2022;14(4)doi:10.3390/pharmaceutics14040884
  5. KalantarMotamedi Y, Ejeian F, Sabouhi F, et al. Transcriptional drug repositioning and cheminformatics approach for differentiation therapy of leukaemia cells. Sci Rep. Jun 15 2021;11(1):12537. doi:10.1038/s41598-021-91629-x
  6. Sultana T, Jan U, Lee H, Lee H, Lee JI. Exceptional Repositioning of Dog Dewormer: Fenbendazole Fever. Current Issues in Molecular Biology. 2022;44(10):4977-4986.
  7. Yamaguchi T, Shimizu J, Oya Y, Horio Y, Hida T. Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information. Case Rep Oncol. May-Aug 2021;14(2):886-891. doi:10.1159/000516276

Panacur® and Safe-Guard® are registered trademarks of Merck Animal Health USA

Topics


Advertisement

Did You Find This Helpful? Share It with Your Pack!

Use the buttons to share what you learned on social media, download a PDF, print this out, or email it to your veterinarian.

Advertisement

Advertisement

Editor's Picks

Advertisement

RELATED ARTICLES